Khetemenee Lam

Development of PF-06671008, a Highly Potent Anti-P-cadherin/Anti-CD3 Bispecific DART Molecule with Extended Half-Life for the Treatment of Cancer

Wei Cao, Bilian Li, Peter LaPan et al. · Antibodies · 2016 · 95 citations · Full text

Pharmacy, Immunology, Medicinal Chemistry +17

Improving the pharmacokinetic properties of biologics by fusion to an anti-HSA shark VNAR domain

Mischa Müller, Kenneth Saunders, Christopher Grace et al. · mAbs · 2012 · 87 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Transient CHO expression platform for robust antibody production and its enhanced N‐glycan sialylation on therapeutic glycoproteins

Xiaotian Zhong, Weijun Ma, Caryl Meade et al. · Biotechnology Progress · 2018 · 46 citations

Life Sciences, Biochemistry, Biotechnology +16

Structure-function relationships of the soluble form of the antiaging protein Klotho have therapeutic implications for managing kidney disease

Xiaotian Zhong, Srinath Jagarlapudi, Yan Weng et al. · Journal of Biological Chemistry · 2020 · 30 citations · Full text

Life Sciences, Biochemistry, Nephrology +15

Quantitative Analysis of Target Coverage and Germinal Center Response by a CXCL13 Neutralizing Antibody in a T-Dependent Mouse Immunization Model

Joanne Brodfuehrer, Andrew L. Rankin, Jason Edmonds et al. · Pharmaceutical Research · 2013 · 20 citations

Life Sciences, Immunology, Cellular Immunology +16